Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
RGLD:NASDAQ
Royal Gold Inc
$251.25
-0.12%
(-0.29) 1D
$251.25
0.00% (0.00)
After hours
Closed: Apr 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGLD...
Open
$249.74
High
$253.72
Low
$245.37
Mkt. cap
21.32B
Avg. vol.
1.19M
Volume
358.00
Dividend
0.76%
Quarterly dividend
$0.47
Ex dividend date
Apr 2, 2026
P/E ratio
37.48
52-wk high
$306.25
52-wk low
$150.75
EPS
$6.70
Beta
0.55
Shares outstanding
84.84M
No. of employees
39
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
1 day ago
Liquidity Mapping Around (RGLD) Price Events
Profile
Royal Gold is a precious metal streaming management company. Wikipedia
About Royal Gold Inc
CEO-
Employees39
Founded1986
HeadquartersDenver, Colorado, United States
SectorGold
Websiteroyalgold.com
Next call in 13 days
Thu, May 7, 12:00 PM
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (2.81 est.)USD
Revenue / Estimate
-/ (475.68M est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
191.68M
207.44M
249.65M
373.10M
Cost of goods sold
24.51M
24.18M
31.39M
50.85M
Cost of revenue
24.51M
24.18M
31.39M
50.85M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.06M
10.27M
10.21M
17.64M
Operating expense
44.06M
41.42M
43.12M
97.67M
Total operating expenses
68.56M
65.60M
74.51M
148.52M
Operating income
123.11M
141.84M
175.14M
224.58M
Other non operating income
-
-
-516.00K
-3.00M
EBT including unusual items
123.97M
143.01M
160.51M
146.38M
EBT excluding unusual items
124.00M
143.01M
173.31M
209.74M
Income tax expense
10.39M
10.54M
28.70M
52.66M
Effective tax rate
8.38%
7.37%
17.88%
35.97%
Other operating expenses
-
-
-
-
Net income
113.50M
132.35M
126.82M
93.61M
Net profit margin
59.21%
63.80%
50.80%
25.09%
Earnings per share
1.51
1.81
2.06
1.92
Interest and investment income
2.05M
2.71M
6.78M
2.87M
Interest expense
-1.16M
-1.54M
-8.10M
-14.70M
Net interest expenses
893.00K
1.17M
-1.32M
-11.83M
Depreciation and amortization charges
33.00M
31.15M
32.90M
80.03M
EBITDA
156.11M
172.99M
208.04M
304.61M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer